
Humanext N 40IU/ml Injection
Marketer
Cadila Pharmaceuticals Ltd
Salt Composition
Insulin Isophane (40IU)
Overview Humanext N 40IU/ml Injection
Insumax N 40IU/ml Injection aids in managing blood glucose levels for adults and children diagnosed with type 1 and type 2 diabetes. This intermediate-acting insulin helps regulate blood sugar, minimizing the risk of severe diabetic complications. Insumax N 40IU/ml Injection is frequently used in conjunction with rapid-acting insulin or oral hypoglycemics. Proper subcutaneous injection technique will be demonstrated by your healthcare provider. Discontinue use only under physician guidance, as it's a crucial component of a comprehensive diabetes management plan encompassing diet, exercise, and weight control as recommended. Consistent blood glucose monitoring, record-keeping, and sharing of results with your doctor are essential for optimal dosage adjustment. Hypoglycemia (low blood sugar) is a common side effect; precise dosing, regular meals, and diligent blood sugar monitoring are crucial for prevention. Excessive alcohol consumption can also induce hypoglycemia. Injection site reactions, such as redness or swelling, may occur. Lipodystrophy (skin changes at the injection site) can result from repeated injections in the same location. Weight gain and edema (generalized swelling) are potential side effects. Avoid use if experiencing hypoglycemia. Prior to treatment, disclose any history of kidney, liver, or heart disease. Pregnant or lactating individuals require consultation with their physician for potential dosage modifications.
Primary Ingredients of Humanext N 40IU/ml Injection
No information provided. Please provide the text you wish to be rewritten.
Uses of Humanext N 40IU/ml Injection
High blood sugar condition
Major Benefits of Humanext N 40IU/ml Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Humanext N 40IU/ml Injection:
- Hypoglycemia (low blood glucose level)
How to use Humanext N 40IU/ml Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Humanext N 40IU/ml Injection works:
Humanext N 40 IU/ml Injection, an insulin analog with an intermediate action profile, initiates its effect within one to two hours post-administration. Its mechanism mirrors endogenous insulin production, promoting glucose uptake by muscle and adipose tissue while simultaneously inhibiting hepatic glucose output. This combined action contributes to glycemic control in patients with diabetes mellitus.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while using Humanext N 40IU/ml Injection is inadvisable.
PregnancySAFE IF PRESCRIBED
The injectable medication Humanext N 40IU/ml is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; however, data from human trials are currently scarce.
Breast feedingSAFE IF PRESCRIBED
Lactation and Humanext N 40IU/ml Injection pose no known safety risk. Research in humans indicates negligible transfer of the medication into breast milk, presenting minimal hazard to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with kidney impairment should use Humanext N 40IU/ml Injection cautiously, as dose modification may be necessary. Physician consultation is advised. Routine blood glucose level checks are recommended to guide dosage adjustments.
LiverCAUTION
Individuals with hepatic impairment should use Humanext N 40 IU/mL Injection cautiously, potentially requiring dosage modification. Physician consultation is advised. Consistent glucose level monitoring is recommended to guide dosage adjustments.
What if you forget to take Humanext N 40IU/ml Injection :
NA
Facts to Know About Humanext N 40IU/ml Injection
| Label | Value |
|---|---|
| Chemical Category | Modified insulin |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Actions | Intermediate-acting human insulin |
